approval · primary record
ROZANOLIXIZUMAB-NOLI
FDA · BLA · 2025-12-09
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-12-09 |
| Brand | RYSTIGGO |
| Sponsor | UCB INC |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:29:30.600Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ROZANOLIXIZUMAB-NOLI:2025-12-09
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.